fitforthem
about

scope and guide to the platform

—research groups

research groups network graph visualization

—repositories

catalog of the institutional repositories

—heritage

selection of collections, museum, cultural sites and ancient books

By continuing your visit to this site, you accept the use of essential cookies.

Read more
6533b838fe1ef96bd12a4f2d

RESEARCH PRODUCT

Influence of CYP2D6 polymorphism on the cytotoxicity of the designer drug 4-methylthioamphetamine (4-MTA)

Niels KrebsfaengerMatthias HermesD. De BoerJan G. HengstlerFranz OeschFélix CarvalhoMarc BrulportJohannes DoehmerFernando RemiãoMaria De Lourdes BastosHelena CarmoMichael R. Schön

subject

Designer drugCyp2d6 polymorphism4-MethylthioamphetamineChemistrymedicine.drug_classmedicineGeneral MedicinePharmacologyToxicologyCytotoxicitymedicine.drug
yearjournalcountryeditionlanguage
2007-10-01Toxicology Letters
https://doi.org/10.1016/j.toxlet.2007.05.134
EU flag

FORTHEM European University Alliance is co-funded by the European Union. FIT FORTHEM has received funding from the European Union's Horizon 2020 Research and Innovation Programme under grant agreement No. 101017248. The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission.

University of Jyväskylä logoUniversity of Jyväskylä's websiteUniversity of Burgundy logoUniversity of Burgundy's websiteUniversity of Mainz logoUniversity of Mainz's websiteUniversity of Palermo logoUniversity of Palermo's websiteUniversity of Latvia logoUniversity of Latvia's website
University of Agder logoUniversity of Agder's websiteUniversity of Opole logoUniversity of Opole's websiteUniversity of Sibiu logoUniversity of Sibiu's websiteUniversity of València logoUniversity of València's website
FORTHEM logoFORTHEM alliance's website